Risks of troglitazone apparent before approval in USA.
Cohen
J S
JS
D002839:Chromans / Q000009:adverse effects* / Q000592:standards; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D018570:Risk Assessment; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000592:standards; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077288:Troglitazone